跳至主要内容
临床试验/CTRI/2019/08/020654
CTRI/2019/08/020654已完成1 期

Double blind, placebo controlled, cross-over clinical study to evaluate the effect of debittered and defatted fenugreek flakes on 24 hour glycemic response

Indus Biotech PvtLtd0 个研究点目标入组 21 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adults with known diabetes
  • Not on insulin treatment
  • BMI <18.5kg/ m2 - >30kg/ m2
  • HbA1c between 7% to 11%
  • On stable anti-hypertensive and lipid lower medication
  • Volunteers willing to give informed consent

排除标准

  • Type 1 diabetes subjects
  • Females who are pregnant, lactating or planning to become pregnant
  • Known food or drug allergy
  • Subjects with any eating disorder or lactose intolerance
  • chronic disease of heart, liver, kidney.
  • Subject participating simultaneously or 3 months prior to screening in any other clinical trial.
  • Subjects who are already consuming Fenugreek in soaked or powder form on daily basis.

研究者

发起方
Indus Biotech PvtLtd

相似试验